Clinicopathological feature and treatment pattern of esophageal cancers in China: the CHANNEL study

Study identification

• EU PAS number:
  EUPAS48396
• Study ID:
  48397
• Official title and acronym:
  Clinicopathological feature and treatment pattern of esophageal cancers in China: the CHANNEL study
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Beijing Cancer Hospital

Study timelines

Date when funding contract was signed

Actual:06/11/2020

Study start date

Actual:18/09/2021

Date of final study report

Planned:30/12/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MSD (China) Holding Co., Ltd.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable